Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.44 USD | -1.88% | -0.10% | +25.63% |
Mar. 12 | HC Wainwright Adjusts IGM Biosciences Price Target to $12 From $7, Maintains Neutral Rating | MT |
Mar. 07 | Earnings Flash (IGMS) IGM BIOSCIENCES Reports Q4 Revenue $651,000 | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock
- Equities
- Stock IGM Biosciences, Inc. - Nasdaq
- Revisions IGM Biosciences, Inc.